Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a lethal chronic lung disease characterized by aberrant intercellular communication, extracellular matrix deposition, and destruction of functional lung tissue. While extracellular vesicles (EVs) accumulate in the IPF lung, their cargo and biological effects remain unclear. We interrogated the proteome of EV and non-EV fractions during pulmonary fibrosis and characterized their contribution to fibrosis. EVs accumulated 14 days after bleomycin challenge, correlating with decreased lung function and initiated fibrogenesis in healthy precision-cut lung slices. Label-free proteomics of bronchoalveolar lavage fluid EVs (BALF-EVs) collected from mice challenged with bleomycin or control identified 107 proteins enriched in fibrotic vesicles. Multiomic analysis revealed fibroblasts as a major cellular source of BALF-EV cargo, which was enriched in secreted frizzled related protein 1 (SFRP1). Sfrp1 deficiency inhibited the activity of fibroblast-derived EVs to potentiate lung fibrosis in vivo. SFRP1 led to increased transitional cell markers, such as keratin 8, and WNT/β-catenin signaling in primary alveolar type 2 cells. SFRP1 was expressed within the IPF lung and localized at the surface of EVs from patient-derived fibroblasts and BALF. Our work reveals altered EV protein cargo in fibrotic EVs promoting fibrogenesis and identifies fibroblast-derived vesicular SFRP1 as a fibrotic mediator and potential therapeutic target for IPF.

Authors

Institutions

Publication Details

Journal
JCI Insight
Published
2024-08-15
DOI
https://doi.org/10.1172/jci.insight.168889
Citations
27
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
6.31

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis

Herbert B. Schiller, Anne Hilgendorff, Oliver Eickelberg, Tanyalak Parimon et al.
27 citations
JCI Insight
Extracellular vesicles in disease
6.31
article

Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis

Herbert B. Schiller, Anne Hilgendorff, Oliver Eickelberg, Tanyalak Parimon, Christina Coughlan, Anna Lena Jung, M. Camila Melo-Narváez, Thomas Heimerl, Adriana Estrada‐Bernal, Mareike Lehmann, Michael Lindner, Q. Hu, Clemens Ruppert, Gert Bange, Jeanine C. Pestoni, Olivier Burgy, Bernd Schmeck, Beatriz Ballester, Yixin She, Christoph H. Mayr, Déborah Schenesse, Arunima Sengupta, Mélanie Königshoff, Gerald Burgstaller, Ali Önder Yildirim, Matthias Mann, Peter Chen, Andreas Güenther, Molly Mozurak, Ugochi Onwuka, Eshita Jain, Efthymios Fousekis Papakonstantinou
article en
27 citations

Abstract

Idiopathic pulmonary fibrosis (IPF) is a lethal chronic lung disease characterized by aberrant intercellular communication, extracellular matrix deposition, and destruction of functional lung tissue. While extracellular vesicles (EVs) accumulate in the IPF lung, their cargo and biological effects remain unclear. We interrogated the proteome of EV and non-EV fractions during pulmonary fibrosis and characterized their contribution to fibrosis. EVs accumulated 14 days after bleomycin challenge, correlating with decreased lung function and initiated fibrogenesis in healthy precision-cut lung slices. Label-free proteomics of bronchoalveolar lavage fluid EVs (BALF-EVs) collected from mice challenged with bleomycin or control identified 107 proteins enriched in fibrotic vesicles. Multiomic analysis revealed fibroblasts as a major cellular source of BALF-EV cargo, which was enriched in secreted frizzled related protein 1 (SFRP1). Sfrp1 deficiency inhibited the activity of fibroblast-derived EVs to potentiate lung fibrosis in vivo. SFRP1 led to increased transitional cell markers, such as keratin 8, and WNT/β-catenin signaling in primary alveolar type 2 cells. SFRP1 was expressed within the IPF lung and localized at the surface of EVs from patient-derived fibroblasts and BALF. Our work reveals altered EV protein cargo in fibrotic EVs promoting fibrogenesis and identifies fibroblast-derived vesicular SFRP1 as a fibrotic mediator and potential therapeutic target for IPF.

JCI InsightVol. 9(18)
Cedars-Sinai Medical Center (US), Inserm (FR), Philipps University of Marburg (DE), University of Pittsburgh (US), Université de Bourgogne (FR), Justus-Liebig-Universität Gießen (DE), Paracelsus Medical University (AT), Universidad Cardenal Herrera CEU (ES), Helmholtz Zentrum München (DE), Geriatric Research Education and Clinical Center (US), German Center for Lung Research (DE), Universities of Giessen and Marburg Lung Center (DE), VA Pittsburgh Healthcare System (US), Maison des Sciences sociales et des Humanités de Dijon (FR), Loewe Center for Synthetic Microbiology (DE), Max Planck Institute of Biochemistry (DE), Ludwig-Maximilians-Universität München (DE), University of Colorado Denver (US)
Agence Nationale de la Recherche
Zero hunger
Openalex Percentile: Top 3%
Extracellular vesicles in disease
6.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.